{
  "id": "82a62e66379fc0d9",
  "title": "U . S . FDA Approves Agio AQVESME\u2122 ( mitapivat ) for the Treatment of Anemia in Adults with Alpha - or Beta - Thalassemia",
  "description": "20251224T040000Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/24/1418617/u-s-fda-approves-agios-aqvesme-mitapivat-for-the-treatment-of-anemia-in-adults-with-alpha-or-beta-thalassemia/",
  "published_at": "20251224T040000Z",
  "fetched_at": "2025-12-25T00:22:49.565695+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/24/1418617/u-s-fda-approves-agios-aqvesme-mitapivat-for-the-treatment-of-anemia-in-adults-with-alpha-or-beta-thalassemia/",
    "url_mobile": "",
    "title": "U . S . FDA Approves Agio AQVESME\u2122 ( mitapivat ) for the Treatment of Anemia in Adults with Alpha - or Beta - Thalassemia",
    "seendate": "20251224T040000Z",
    "socialimage": "https://ml.globenewswire.com/media/NTFiZDQ5ODgtZjA3Zi00NzA0LTkzNmYtYTFiMjQwNTQxODJmLTEwMTk3OTEtMjAyNS0xMi0yNC1lbg==/tiny/Agios-Pharmaceuticals-Inc-.png",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}